Completed Published inThe LancetTime PeriodCOVID-19ShareTwitter-xFacebookShare-emailCopy URL to clipboard Can Sino Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
